Zyryanov S.K. - Список публикаций

Список записей

Отображать:

ЭКОНОМИЧЕСКАЯ ЦЕЛЕСООБРАЗНОСТЬ ПРИМЕНЕНИЯ ИММУНОБИОЛОГИЧЕСКОГО ПРЕПАРАТА ОМАЛИЗУМАБ У ПАЦИЕНТОВ С ТЯЖЕЛОЙ БРОНХИАЛЬНОЙ АСТМОЙ В УСЛОВИЯХ ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ

Article

Зырянов С.К., Белевский А.С., Дьяков И.Н.

Астма и аллергия. 2019. С. 28-37

EFFICIENCY AND SAFETY OF OPIOID THERAPY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH CANCER OF THE REFRACTORY IRON: CLINICO-PATHOGENETIC FEATURES

Article

Bobrova O.P., Schneider N.A., Petrova M.M., Dmitrenko D.V., Zyryanov S.K., Zobova S.N.

Экспериментальная и клиническая гастроэнтерология. 2019. С. 45-51

SERIOUS ADVERSE DRUG REACTIONS WITH LETHAL OUTCOMES: ANALYSIS OF THE RUSSIAN PHARMACOVIGILANCE DATABASE

Article

Shmaevskij P.E., Kosyakina N., Cigura D.A., Zatolochina K.E., Zyryanov S.K., Asetskaya I.L., Kazakov A.S.

SCIENCE4HEALTH 2019. Клинические и теоретические аспекты современной медицины. 2019. 142 с.

AGE PECULIARITIES OF PHARMACOTHERAPY WITH AMOXICILLIN PREPARATIONS IN CHILDREN WITH CYSTIC FIBROSIS

Article

Kondratieva E.I., Kondakova Y.A., Zyryanov S.K., Bondareva I.B., Voronkova A.Y., Sherman V.D., Melyanovskaya Y.L., Odinayeva N.D., Dronov I.A.

Pediatriya - Zhurnal im G.N. Speranskogo. Том 98. 2019. С. 179-188

THE FIRST RUSSIAN CONSENSUS ON QUANTITATIVE ASSESSMENT OF TREATMENT OUTCOME

Article

Arutyunov A.G., Bojcov S.A., Viktorova I.A., Vlasov V.V., Voevoda M.I., Vorob'yov P.A., Drapkina O.M., Zadionchenko V.S., Zarubina T.V., Zyryanov S.K., Karpov R.S., Kobalava Z.D., Kolbasnikov S.V., Lazebnik L.B., Livzan M.A., Malyavin A.G., Martynov A.I., Medvedeva I.V., Moiseev S.V., Napalkov D.A. ...

Medical News of North Caucasus. Том 14. 2019. С. 283-301

CLINICAL AND ECONOMIC STUDIES ON PHARMACOTHERAPY OF MALIGNANT NEOPLASMS: THE MODELING APPROACH

Article

Tolkushin A.G., Zyryanov S.K., Pogudina N.L., Davydovskaya M.V.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 11. 2019. С. 48-60

BUDGET IMPACT ANALYSIS OF TERIPARATIDE IN COMPARISON WITH ANTIRE-SORPTIVE DRUGS IN SEVERE OSTEOPOROTIC PATIENTS

Article

Diakov I.N., Belaya Z.E., Zyrianov S.K., Mazurov V.I.

Medical Technologies. Assessment and Choice. 2019. С. 71-80

GERONTOLOGY ISSUES IN CARDIOLOGY PRACTICE

Article

Tkacheva O.N., Belenkov Y.N., Karpov Y.A., Zyryanov S.K.

Kardiologiia. Том 59. 2019. С. 54-63

QUANTIATIVE ANA QUALITATIVE ASSESSMENT OF THE RANGE OF ANTIASTHMA MEDICINES AVAILABLE TO RUSSIAN CONSUMERS

Article

Ivanov D.A., Kubaeva M.B., Zyryanov S.K.

Фармакоэкономика: теория и практика. Том 7. 2019. С. 38-39

PHARMACOECONOMIC ANALYSIS OF USING BIOLOGICAL AGENTS FOR UNCONTROLLED MODERATE-TO-SEVERE ATOPIC ASTHMA IN THE RUSSIAN FEDERATION

Article

Zyryanov S.K., Diyakov I.N., Avdeev S.N.

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. Том 12. 2019. С. 268-278

THE EFFECT OF OPRM1, ABCB1, IL1B, PTGS2, LOC 541472 GENE POLYMORPHISM ON THE VARIABILITY OF CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER

Article

Bobrova Olga, Schnider Natalya, Zyryanov Sergey, Dmitrenko Diana, Zobova Svetlana, Zukov Ruslan

Качественная клиническая практика. 2019. С. 53-59

CARDIOVASCULAR COMPLICATIONS OF IMMUNE CHECKPOINT INHIBITORS

Article

Kulieva A.A., Emelina E.I., Gendlin G.E., Nikitin I.G., Zyryanov S.K., Varentsov S.I., Zakharova I.I.

Качественная клиническая практика. 2019. С. 55-65

SAFETY AND TOLERABILITY OF NSAIDS: FOCUS ON ACECLOFENAC

Article

Ushkalova E.A., Zyryanov S.K., Zalolochina K.E.

Медицинский совет. 2019. С. 110-120

CHRONIC PAIN SYNDROME IN PATIENTS WITH PANCREATIC CANCER: INDIVIDUAL THERAPY AND ITS PATHOGENETIC BACKGROUND

Article

Bobrova O.P., Shnayder N.A., Dychno Y.A., Zyryanov S.K., Petrova M.M.

Russian Open Medical Journal. Том 8. 2019.

PHARMACOLOGY IN SPECIAL POPULATIONS: EXTREME AGE

Article

Romanov B.K., Zyryanov S.K.

Качественная клиническая практика. 2019. С. 70-74

DRUG ADJUSTMENT OF MODIFIED RISK FACTORS AS ONE OF THE LEADING STRATEGIES FOR MANAGING PATIENTS WITH CARDIOVASCULAR DISEASES

Article

Zyryanov S.K., Baybulatova E.A.

Медицинский совет. 2019. С. 22-38

PHARMACOKINETICS OF ANTI-BACTERIAL PREPARATIONS IN CYSTIC FIBROSIS IN CHILDREN

Article

Kondakova Y.A., Voronkova A.Y., Zyryanov S.K., Bondareva I.B.

Сибирское медицинское обозрение. 2019. С. 5-13

CLINICAL AND ECONOMIC EFFICIENCY OF TREATMENT WITH DAPAGLIFLOZIN OF PATIENTS WITH TYPE 2 DIABETES MELLITUS IN RUSSIAN HEALTH CARE CONDITIONS

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. 2019. С. 23-32

THERAPEUTIC DRUG MONITORING OF LEVETIRACETAM IN NEWBORNS

Article

Bondareva I.B., Ivzhits M.A., Zyryanov S.K., Chenkurov M.S.

Анналы клинической и экспериментальной неврологии. Том 13. 2019. С. 65-76

MODERN APPROACHES TO IMPROVING THE EFFECTIVENESS OF ANTIBIOTIC THERAPY IN PERINATOLOGY: LOCAL EXPERIENCE

Article

Kazanova A.M., Zyryanov S.K., Ivzhits M.A., Kruglov A.N., Kutsaya K.O., Chenkurov M.S.

Качественная клиническая практика. 2019. С. 66-74

PREVALENCE OF POTENTIALLY INAPPROPRIATE MEDICATIONS AMONG ELDERLY PATIENTS IN CLINICAL PRACTICE

Article

Al-Rajavi A., Zyryanov S.K., Ushkalova E.A., Butranova O.I., Pereverzev A.P.

Качественная клиническая практика. 2019. С. 57-65

CLINICAL AND ECONOMIC ANALYSIS OF THE AXITINIB AS A SECOND-LINE TARGET THERAPY FOR PATIENTS WITH ADVANCED RENAL CELL CARCINOMA

Article

Zyrianov S.K., Diakov I.N.

Medical Technologies. Assessment and Choice. Том 36. 2019. С. 59-68

PHARMACOECONOMIC EVALUATION OF CEFTOLOSAN + TASOBACTAM IN THE TREATMENT OF COMPLICATED NOSOCOMIAL INTRA-ABDOMINAL INFECTIONS

Article

Zyryanov S.K., Dyakov I.N., Khachatryan N.N.

Качественная клиническая практика. 2019. С. 55-69

PHARMACOECONOMIC ANALYSIS OF FLEXIBLE-DOSE ADMINISTRATION REGIMEN OF XEOMINE® IN PATIENTS WITH FOCAL DYSTONIA

Article

Cheberda A.E., Belousov D.Yu., Zyryanov S.K.

Качественная клиническая практика. 2018. С. 53-65

PHARMACOECONOMIC ASSESSMENT OF DUAL BRONCHODILATION THERAPY IN PATIENTS WITH COPD

Article

Zyryanov S.K., D'yakov I.N.

Pulmonologiya. Том 28. 2018. С. 61-68

EXTRACELLULAR DNA AND PLASMA NUCLEASE ACTIVITY EFFECT ON THE COURSE OF THE MICROBIAL INFLAMMATORY PROCESS IN THE RESPIRATORY TRACT IN CYSTIC FIBROSIS

Article

Kondratieva E.I., Kondakova Yu.A., Kostyuk S.V., Ershova E.V., Zyryanov S.K., Melyanovskaya Yu.L., Voronkova A.Yu., Sherman V.D., Shadrina V.V.

Journal of Bioinformatics and Genomics. 2018. 2 с.

РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ "ЭМПИРИЧЕСКАЯ АНТИБАКТЕРИАЛЬНАЯ ТЕРАПИЯ ИНФЕКЦИЙ ДЫХАТЕЛЬНЫХ ПУТЕЙ С УЧЕТОМ ФАКТОРОВ РИСКА РЕЗИСТЕНТНОЙ ФЛОРЫ"

Article

Козлов Р.С., Зырянов С.К., Синопальников А.И., Рязанцев С.В., Стырт Е.А.

Справочник поликлинического врача. 2018. С. 28-32

HEALTH TECHNOLOGY ASSESSEMENT OF THE FIXED COMBINATION OF INSULIN GLARGINE 100 UI/ML AND LIXISENATIDE IN THE TREATMENT INTENSIFICATION OF DIABETES MELLITUS TYPE 2

Article

Ziryanov S.K., Dyakov I.N.

Качественная клиническая практика. 2018. С. 4-13

ТЕРАПИЯ БРОНХИАЛЬНОЙ АСТМЫ У ДЕТЕЙ: ИНГАЛЯЦИОННЫЕ ГЛЮКОКОРТИКОСТЕРОИДЫ VS. АНТАГОНИСТЫ ЛЕЙКОТРИЕНОВЫХ РЕЦЕПТОРОВ (ОБЗОР ЛИТЕРАТУРЫ)

Article

Переверзев А.П., Зырянов С.К., Ушкалова Е.А., Чельцов В.В.

Consilium Medicum. Том 20. 2018. С. 40-44

CLINICAL AND ECONOMIC EVALUATION OF USING FIXED DOSE DUAL BRONCHODILATOR COMBINATION TIOTROPIUMOLODATEROL IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Article

Zyryanov S.K., Galatonova Y.A.

Медицинский совет. 2018. С. 61-65

GENERIC SUBSTITUTIONS OF ANTIEPILEPTIC DRUGS: IS IT POSSIBLE TO PUT AN END TO THE DISCUSSION?

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Том 10. 2018. С. 75-80

ФАРМАКОЭКОНОМИЧЕСКОЕ ИССЛЕДОВАНИЕ ПРЕПАРАТОВ, ПРИМЕНЯЕМЫХ ПРИ ЛЕЧЕНИИ ПСОРИАЗА СРЕДНЕТЯЖЕЛОЙ И ТЯЖЕЛОЙ СТЕПЕНИ У ПАЦИЕНТОВ С НЕЭФФЕКТИВНОСТЬЮ БАЗОВОЙ СИСТЕМНОЙ ТЕРАПИИ

Article

Зырянов С.К., Белоусов Д.Ю., Чеберда А.Е.

Клиническая фармакология и терапия. Том 27. 2018. С. 91-97

PHARMACOECONOMICS EXPEDIENCY OF APPLICATION OF THE COMBINED PREPARATION OF VEZOMNI IN COMPARISON WITH A COMBINATION OF TAMSULOSIN AND SOLIFENACIN IN THE FORM OF MONOPREPARATIONS

Article

Zyryanov S.K., Dyakov I.N.

Качественная клиническая практика. 2018. С. 35-40

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS

Article

Zyryanov S.K., Cheberda A.E., Belousov D.Y.

Rational Pharmacotherapy in Cardiology. Том 14. 2018. С. 167-175

METHODS OF PHARMACOLOGICAL TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION CURRENT APPROACHES TO THE PATIENTS MANAGEMENT

Article

Ushkalova E.A., Zyryanov S.K., Zatolochina K.E.

Kardiologiia. Том 58. 2018. С. 82-93

GCP INSPECTION BY ROSZDRAVNADZOR

Article

Belousov D.Yu., Zyryanov S.K., Kolbin A.S., Karpenko L.I., Rogov E.S.

Качественная клиническая практика. 2018. С. 66-76

PRINCIPLES OF SELECTION AND DOSING OF ANTIBACTERIAL AGENTS IN PATIENTS WITH HEPATIC FAILURE

Article

Ushkalova E.A., Zyryanov S.K., Pereverzev A.P.

Хирург. 2018. С. 75-88

PHARMACOKINETIC AND PHARMACOGENETIC ASPECTS OF PERSONALIZED ANALGETIC THERAPY WITH FENTANIL TTS IN CLINICAL ONCOLOGY

Article

Bobrova O.P., Dyhno Y.A., Shnayder N.A., Petrova M.M., Zyryanov S.K.

Siberian Journal of Oncology. Том 17. 2018. С. 94-100

LEVOFLOXACIN: ANALYSIS OF INFORMATION ON ADVERSE REACTIONS FROM RUSSIAN SPONTANEOUS REPORT DATABASE

Article

ZYRYANOV S.K., ZATOLOCHINA K.E., ASETSKAYA I.L.

Antibiotiki i Khimioterapiya. Том 63. 2018. С. 46-51

IN VITRO EQUIVALENCE EVALUATION OF BETAHISTINE GENERIC MEDICINAL PRODUCTS AS A TOOL POTENTIALLY DETERMINING THE EFFICACY OF PHARMACOTHERAPY [OTSENKA ÉKVIVALENTNOSTI IN VITRO VOSPROIZVEDENNYKH PREPARATOV BETAGISTINA KAK INSTRUMENTA, POTENTSIAL'NO OPREDELIAIUSHCHEGO ÉFFEKTIVNOST' FARMAKOTERAPII]

Article

Zyryanov S.K., Butranova O.I., Ramenskaya G.V., Gildeeva G.N., Shohin I.E.

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. Том 118. 2018. С. 43-48

PHARMACOECONOMIC ANALYSIS OF AFATINIB AND GEFITINIB FOR THE TREATMENT OF LUNG CANCER

Article

Fedyayev D.V., Zyryanov S.K.

Medical Technologies. Assessment and Choice. 2018. С. 68-84

OPTIMIZATION OF EPILEPSY PHARMACOTHERAPY BASED ON A PERSONALIZED APPROACH TO DRUG SAFETY ASSESSMENT

Article

Bochanova E.N., Shnayder N.A., Zyryanov S.K., Gusev S.D., Nasyrova R.F.

Доктор.Ру. 2018. С. 13-18

GENETICALLY ENGINEERED DRUGS FOR TREATMENT OF BRONCHIAL ASTHMA: RECENT ACHIEVEMENTS

Article

Zyryanov S.K., Butranova O.I.

Pulmonologiya. Том 28. 2018. С. 584-601

MODERN PROBLEMS OF SURGICAL INFECTIONS OF THE SKIN AND SOFT TISSUES CAUSED BY MRSA, AND THE WAYS OF THEIR SOLUTION

Article

Zyryanov S.K., Sychyov I.N.

Хирург. 2018. С. 31-43

CLINICO-PHARMACOLOGICAL CHARACTERISTICS OF OPIOID DRUG-DRUG INTERACTIONS IN CANCER PATIENTS WITH CHRONIC PAIN SYNDROME

Article

Bobrova O.P., Shnayder N.A., Zyryanov S.K., Dykhno Y.A., Petrova M.M., Nasyrova R.F.

Siberian Journal of Oncology. Том 17. 2018. С. 114-122

ОПАСНЫЕ СВЯЗИ

Article

Зырянов С.К.

StatusPraesens. Педиатрия и неонатология. 2018. С. 40-46

MODERN MASKS OF INFECTIOUS ENDOCARDITIS

Article

Rodoman G.V., Sumedi I.R., Zyryanov S.K., Ivzhits M.A., Kurmashev A.F., Ionidi P.V., Putsman G.A., Kuchuk A.O.

Antibiotiki i Khimioterapiya. Том 63. 2018. С. 18-27

PERSPECTIVE FOR USE OF THE RADIONUCLIDE DRUGS IN THE TREATMENT OF MALIGNANT TUMORS IN RUSSIA

Article

Zyryanov S.K., Zatolochina K.E.

Качественная клиническая практика. 2018. С. 51-57

PHARMACOEPIDEMIOLOGY OF ANTIBACTERIAL DRUGS FOR PRETERM INFANTS

Article

Dyrina K.S., Uvarova E.S., Kutsaya K.O., Zyryanov S.K., Zyryanov S.K.

Клинические и теоретические аспекты современной медицины. 2018. 69 с.

PHARMACOVIGILANCE SYSTEM IN EURASIAN ECONOMIC UNION

Article

Asetskaya I.L., Zyryanov S.K., Kolbin A.S., Belousov D.Yu.

Качественная клиническая практика. 2018. С. 53-72

Страница 5 из 7. Записи с 201 по 250 из 349

Другие авторы

Velibekov M.C.

Записей: 1

Gorbatenko R.G.

Записей: 11